Global Radio Frequency Identification (RFID) In Pharmaceuticals Market Overview: Trends Shaping Growth to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Radio Frequency Identification (RFID) In Pharmaceuticals Industry Expected To Reach By 2029, Starting From 2025 Levels?

The radio frequency identification (RFID) in pharmaceuticals market has experienced substantial growth in recent years. It is projected to expand from $5.48 billion in 2024 to $6.08 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.9%. This historical development can be attributed to an increase in pharmaceutical exports, the rise of e-commerce, an uptick in clinical trials, the growing demand for tamper-evident RFID solutions, and the emergence of patient-centric healthcare delivery models.

The radio frequency identification (RFID) in pharmaceuticals market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $9.12 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.7%. This projected growth over the forecast period stems from factors such as the rising occurrences of counterfeit medications, heightened healthcare awareness, expanding hospital automation, an increased need for real-time tracking, and greater investment in digital supply chain solutions. Key trends for this period encompass technological progress, improvements in radio frequency identification tag designs, the incorporation of cloud-based platforms, innovations in pharmaceutical-specific inlays, and further developments in supply chain digitization.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25891&type=smp

Which Industry Drivers Are Expected To Accelerate The Radio Frequency Identification (RFID) In Pharmaceuticals Market From 2025 To 2029?

The rising occurrence of fake medicines is projected to drive expansion in the radio frequency identification (RFID) in pharmaceuticals market in the future. Counterfeit drugs, also known as counterfeit medicines, refer to pharmaceutical items intentionally and deceitfully mislabeled regarding their origin or identity. The surge in counterfeit drug incidents stems from the rapid proliferation of online pharmacies, which has facilitated counterfeiters in supplying false medications straight to consumers, thus circumventing established regulatory protections and complicating their detection. Radio frequency identification (RFID) in pharmaceuticals aids in combating counterfeit drugs by offering secure, trackable data that confirms product genuineness throughout the entire supply chain. For example, as reported in December 2024 by the American Chemical Society, a US-based nonprofit scientific society, there were 6,987 documented counterfeit drug incidents across 142 countries in 2023, marking a 4% rise from 2022. Consequently, the growing frequency of counterfeit drugs is fueling the expansion of the radio frequency identification (RFID) in pharmaceuticals market.

What Are The Leading Segments Analyzed In The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

The radio frequency identification (rfid) in pharmaceuticals market covered in this report is segmented –

1) By Type: Chipped Radio Frequency Identification, Chipless Radio Frequency Identification

2) By Component: Radio Frequency Identification Tags, Radio Frequency Identification Readers, Middleware Software, Integration Services, Data Management Software

3) By Regulatory Compliance: Food And Drug Administration Compliance Standards, European Union Falsified Medicines Directive, Good Distribution Practices, Serialization Requirements, Tracking And Tracing Regulations

4) By Application: Drug Track And Trace System, Asset Tracking, Patient Safety, Other Applications

5) By End-User: Pharmaceutical Manufacturers, Hospitals And Healthcare Providers, Pharmacies And Drug Wholesalers, Research And Development Laboratories, Logistics And Supply Chain Companies

Subsegments:

1) By Chipped Radio Frequency Identification, By Type: Low Frequency Radio Frequency Identification, High Frequency Radio Frequency Identification, Ultra High Frequency Radio Frequency Identification, Active Radio Frequency Identification, Passive Radio Frequency Identification, Semi-Passive Radio Frequency Identification

2) By Chipless Radio Frequency Identification, By Type: Time Domain Reflectometry, Frequency Domain Reflectometry, Magnetic Resonance-Based Tags, Surface Acoustic Wave Tags, Printed Conductive Polymer Tags, Photonic Band Gap Structures

How Are Trends Influencing The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

Leading companies in the radio frequency identification (RFID) in pharmaceuticals market are concentrating on developing sophisticated RFID-enabled labels. This effort aims to improve product traceability, optimize inventory management, and address the increasing threat posed by counterfeit drugs. RFID-enabled labels serve as intelligent tags, utilizing radio frequency technology to wirelessly identify, track, and verify pharmaceutical products throughout their supply chain. For example, in May 2023, Fresenius Kabi AG, a pharmaceutical company based in Germany, launched its Rocuronium Bromide Injection featuring advanced RFID-enabled labeling to enhance medication tracking, inventory control, and patient safety in healthcare settings. This product is provided as a 50 mg per 5 mL multiple-dose vial for intravenous administration by trained medical professionals. The injection incorporates advanced RFID-enabled smart labeling, which allows for real-time tracking, streamlines inventory processes, and aids in reducing medication errors.

Which Key Market Players Are Investing In Expansion And Innovation Of Radio Frequency Identification (RFID) In Pharmaceuticals Market?

Major companies operating in the radio frequency identification (rfid) in pharmaceuticals market are Fujitsu Limited, NXP Semiconductors NV, Avery Dennison Corporation, Zebra Technologies Corporation, CCL Industries Inc., HID Global Corporation, Checkpoint Systems Inc, Datalogic SpA, Impinj Inc, Schreiner Group GmbH & Co KG, Invengo Information Technology Co Ltd, GAO RFID Inc., Lowry Solutions Inc., Terso Solutions Inc., Xerafy Singapore Pte Ltd., Tageos SAS, SML Group Limited, Syrma SGS Technology Limited, Omnia Technologies Private Limited, identytag GmbH & Co KG

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/radio-frequency-identification-rfid-in-pharmaceuticals-global-market-report

Which Geographies Are Emerging As Strong Markets For The Radio Frequency Identification (RFID) In Pharmaceuticals Industry?

North America was the largest region in the radio frequency identification (RFID) in pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radio frequency identification (rfid) in pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Radio Frequency Identification (RFID) In Pharmaceuticals Market Report:

https://www.thebusinessresearchcompany.com/customise?id=25891&type=smp

Browse Through More Reports Similar to the Global Radio Frequency Identification (RFID) In Pharmaceuticals Market 2025, By The Business Research Company

Radio Frequency Identification Rfid Tags Market 2025

https://www.thebusinessresearchcompany.com/report/radio-frequency-identification-rfid-tags-market

Healthcare Rfid Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-rfid-global-market-report

Radio Frequency Identification Rfid Smart Cabinets Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/radio-frequency-identification-rfid-smart-cabinets-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info